{
    "ticker": "CRKN",
    "name": "Cure Pharmaceuticals, Inc.",
    "description": "Cure Pharmaceuticals, Inc. is a pioneering biotechnology company focused on advancing drug delivery systems and therapeutic solutions. Founded in 2015, the company specializes in the development of innovative formulations and delivery mechanisms that enhance the efficacy and safety of pharmaceutical products. Cure Pharmaceuticals is particularly known for its proprietary CureFormulation technology, which allows for the development of oral thin films that dissolve quickly in the mouth, providing rapid release of medications. This technology is poised to revolutionize how drugs are administered, particularly for patients who have difficulty swallowing pills. The company's product portfolio includes treatments for various conditions, ranging from chronic pain to anxiety and insomnia. With a commitment to improving patient outcomes and enhancing the healthcare experience, Cure Pharmaceuticals is actively engaged in research and development as well as strategic partnerships to bring its innovative products to market. The company is driven by a mission to empower patients through improved drug delivery methods and create a more efficient healthcare system.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Los Angeles, California, USA",
    "founded": "2015",
    "website": "https://curepharmaceutical.com",
    "ceo": "Roberto Villalobos",
    "social_media": {
        "twitter": "https://twitter.com/CurePharma",
        "linkedin": "https://www.linkedin.com/company/cure-pharmaceuticals/"
    },
    "investor_relations": "https://curepharmaceutical.com/investor-relations/",
    "key_executives": [
        {
            "name": "Roberto Villalobos",
            "position": "CEO"
        },
        {
            "name": "Michael A. J. H. W. Kaldany",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Drug Delivery Systems",
            "products": [
                "CureFormulation Technology",
                "Oral Thin Films"
            ]
        },
        {
            "category": "Therapeutic Solutions",
            "products": [
                "Pain Management",
                "Anxiety Treatments"
            ]
        }
    ],
    "seo": {
        "meta_title": "Cure Pharmaceuticals, Inc. | Innovative Drug Delivery Solutions",
        "meta_description": "Explore Cure Pharmaceuticals, Inc., a leader in biotechnology dedicated to innovative drug delivery systems and therapeutic solutions. Learn about their commitment to improving patient outcomes.",
        "keywords": [
            "Cure Pharmaceuticals",
            "Biotechnology",
            "Drug Delivery",
            "Therapeutics",
            "CureFormulation",
            "Oral Thin Films"
        ]
    },
    "faq": [
        {
            "question": "What is Cure Pharmaceuticals known for?",
            "answer": "Cure Pharmaceuticals is known for its innovative drug delivery systems, particularly its oral thin film technology."
        },
        {
            "question": "Who is the CEO of Cure Pharmaceuticals?",
            "answer": "Roberto Villalobos is the CEO of Cure Pharmaceuticals, Inc."
        },
        {
            "question": "Where is Cure Pharmaceuticals headquartered?",
            "answer": "Cure Pharmaceuticals is headquartered in Los Angeles, California, USA."
        },
        {
            "question": "What are Cure Pharmaceuticals' main products?",
            "answer": "Cure Pharmaceuticals' main products include its CureFormulation technology and various therapeutic solutions for pain and anxiety."
        },
        {
            "question": "When was Cure Pharmaceuticals founded?",
            "answer": "Cure Pharmaceuticals was founded in 2015."
        }
    ],
    "competitors": [
        "VRTX",
        "AMGN",
        "ABBV"
    ],
    "related_stocks": [
        "JNJ",
        "PFE",
        "MRK",
        "GILD"
    ]
}